1.Efficacy of Benihuuki Green Tea on the Patients with Japanese Cedar Pollinosis
Reiko KISHIKAWA ; Nobuo SOH ; Sadami INOUE ; Masayuki KAMIMURA ; Chiduko KAMORI ; Kenji KAWATA ; Kenichi KURITA ; Takuo JOUZAKI ; Kazuo TAKEDA ; Kenichiroh NOGAMI ; Katsuhiko MIHASHI ; Osamu YADOHISA ; Atsunobu YAMADA ; Yasusi OKUMURA ; Sankei NISHIMA ; Takeru ISHIKAWA
Japanese Journal of Complementary and Alternative Medicine 2007;4(3):127-136
Background: As a complementary medicine we have evaluated the efficacy of Benihuuki green tea, which contains methylated form of tea catechin reported stronger anti-allergic activities than ordinary catechin, on Japanese Cedar Pollinosis (JCP) in comparison with Yabukita green tea, contains ordinary catechin. This study was carried out during the pollination season, Feb.–April, in 2005.
Method: Four hundred eighty six patients with JCP, visiting 12 otorhinolaryngology clinics in Fukuoka prefecture were divided into A and B groups and subjected to quasi-single blind clinical trials. Under ordinary conditions, A-group patients took Benihuuki green tea and B-group took Yabukita green tea every day from February 1st to the end of Japanese cedar and Cupressaceae pollination season. We compared nose and eye symptom scores, medication scores and disturbance of quality of life (QOL).
Result: There were no differences observed between the two groups with respect to their symptom scores and the disturbance of QOL. However, decreasing trend of the medication scores was observed in A-group (p < 0.1).
Conclusion: It has been suggested that Benihuuki green tea is a possible candidate as a complementary medicine for JCP during the pollination season.
2.Predictors for Diarrhea After Administration of Naldemedine: Analysis Focusing on the Administration Period of Opioid Analgesics Before the Start of Naldemedine
Junya HASHIZUME ; Emi RYU ; Seiichi NOSE ; Kei MIYANAGA ; Reiko KISHIKAWA ; Tadahiro NAKAMURA ; Takahiro MURO ; Yukinobu KODAMA ; Haruna YAMASHITA ; Koji ISHII ; Hitoshi SASAKI
Palliative Care Research 2020;15(2):101-109
Purpose: Naldemedine is a peripheral µ-opioid receptor antagonist, including the treatment of opioid-induced constipation (OIC) . However, diarrhea is known as its side effect. We conducted a study focusing on the administration period of opioid analgesics before the start of naldemedine to clear predictors of diarrhea due to Naldemedine. Method: All data were retrospectively collected from the electronic medical record system. We investigated patients who initially administrated naldemedine at Nagasaki University Hospital from June 1 2017 to March 31 2019. Result: One hundred thirty-two patients were subject of investigation. The incidence of diarrhea was 25.0%. The result of the multivariate analysis showed that significant predictors of diarrhea were associated with the opioid analgesics usage period longer than 7 days before naldemedine initiation (odds ratio: 3.76, 95% confidence interval: 1.53-9.20, p=0.004). Discussion: When naldemedine was used for OIC, diarrhea may be avoided by using within 7 days after opioid analgesics.